Please contact our sales team for your Consulting and Customization queries/concerns at [email protected].
Adoption of innovative technologies in screening & diagnostic tests is projected to drive growth. The incorporation of multiparametric MRI (mp-MRI) can significantly improve the detection of tumor and also provide confirmation whether there is a need for tissue biopsy. In addition, market players are investing in research for the development of therapeutic products for the treatment of such tumors. For instance, there is a strong pipeline of products such as Tc-99m (Progenics), radium-223 dichloride (Xofigo, Bayer), ODM-201 (Orion and Bayer), which are in their phase 3 studies and are projected to enter the market in the near future. In addition, many generic products are likely to enter the market owing to the expiry of patents of the major existing products during the forecast period. Thus, these factors are expected to drive growth.
Market Analysis and Insights: Global Prostate Cancer Treatment Drugs Market
The global Prostate Cancer Treatment Drugs market is projected to grow from US$ million in 2023 to US$ million by 2029, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.
Asia Pacific is anticipated to be the fastest growing market over the forecast period. Rising awareness of such tumors would primarily drive growth. Governments of various countries in this region are playing a vital role in creating awareness through programs and online portals that provide detailed information regarding screening & diagnosis through PSA blood tests and DRE for male patients over 50 years of age.
Report Includes
This report presents an overview of global market for Prostate Cancer Treatment Drugs market size. Analyses of the global market trends, with historic market revenue data for 2018 - 2022, estimates for 2023, and projections of CAGR through 2029.
This report researches the key producers of Prostate Cancer Treatment Drugs, also provides the revenue of main regions and countries. Highlights of the upcoming market potential for Prostate Cancer Treatment Drugs, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Prostate Cancer Treatment Drugs revenue, market share and industry ranking of main companies, data from 2018 to 2023. Identification of the major stakeholders in the global Prostate Cancer Treatment Drugs market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by type and by application, revenue, and growth rate, from 2018 to 2029. Evaluation and forecast the market size for Prostate Cancer Treatment Drugs revenue, projected growth trends, production technology, application and end-user industry.
Descriptive company profiles of the major global players, including Johnson & Johnson, Astella, Sanofi, Ipsen, Bayer, AstraZeneca and Dendreon, etc.
By Company
- Johnson & Johnson
- Astella
- Sanofi
- Ipsen
- Bayer
- AstraZeneca
- Dendreon
Segment by Type
- Zytiga
- Gonax
- Lupron
- Zoladex
- Decapeptyl
- Eligard
- Vantas
- Casodex
- Others
Segment by Application
- Hospitals
- Ambulatory Surgical Centers
- Clinics
By Region
- North America
- - United States
- - Canada
- Europe
- - Germany
- - France
- - UK
- - Italy
- - Russia
- - Nordic Countries
- - Rest of Europe
- Asia-Pacific
- - China
- - Japan
- - South Korea
- - Southeast Asia
- - India
- - Australia
- - Rest of Asia
- Latin America
- - Mexico
- - Brazil
- - Rest of Latin America
- Middle East, Africa, and Latin America
- - Turkey
- - Saudi Arabia
- - UAE
- - Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Revenue of Prostate Cancer Treatment Drugs in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. This section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Prostate Cancer Treatment Drugs companies competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: North America by type, by application and by country, revenue for each segment.
Chapter 7: Europe by type, by application and by country, revenue for each segment.
Chapter 8: China by type and by application revenue for each segment.
Chapter 9: Asia (excluding China) by type, by application and by region, revenue for each segment.
Chapter 10: Middle East, Africa, and Latin America by type, by application and by country, revenue for each segment.
Chapter 11: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Prostate Cancer Treatment Drugs revenue, gross margin, and recent development, etc.
Chapter 12: Analyst's Viewpoints/Conclusions
Table of Contents
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Prostate Cancer Treatment Drugs Market Size Growth Rate by Type, 2018 VS 2022 VS 2029
1.2.2 Zytiga
1.2.3 Gonax
1.2.4 Lupron
1.2.5 Zoladex
1.2.6 Decapeptyl
1.2.7 Eligard
1.2.8 Vantas
1.2.9 Casodex
1.2.10 Others
1.3 Market by Application
1.3.1 Global Prostate Cancer Treatment Drugs Market Size Growth Rate by Application, 2018 VS 2022 VS 2029
1.3.2 Hospitals
1.3.3 Ambulatory Surgical Centers
1.3.4 Clinics
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Prostate Cancer Treatment Drugs Market Perspective (2018-2029)
2.2 Global Prostate Cancer Treatment Drugs Growth Trends by Region
2.2.1 Prostate Cancer Treatment Drugs Market Size by Region: 2018 VS 2022 VS 2029
2.2.2 Prostate Cancer Treatment Drugs Historic Market Size by Region (2018-2023)
2.2.3 Prostate Cancer Treatment Drugs Forecasted Market Size by Region (2024-2029)
2.3 Prostate Cancer Treatment Drugs Market Dynamics
2.3.1 Prostate Cancer Treatment Drugs Industry Trends
2.3.2 Prostate Cancer Treatment Drugs Market Drivers
2.3.3 Prostate Cancer Treatment Drugs Market Challenges
2.3.4 Prostate Cancer Treatment Drugs Market Restraints
3 Competition Landscape by Key Players
3.1 Global Revenue Prostate Cancer Treatment Drugs by Players
3.1.1 Global Prostate Cancer Treatment Drugs Revenue by Players (2018-2023)
3.1.2 Global Prostate Cancer Treatment Drugs Revenue Market Share by Players (2018-2023)
3.2 Global Prostate Cancer Treatment Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players of Prostate Cancer Treatment Drugs, Ranking by Revenue, 2021 VS 2022 VS 2023
3.4 Global Prostate Cancer Treatment Drugs Market Concentration Ratio
3.4.1 Global Prostate Cancer Treatment Drugs Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Prostate Cancer Treatment Drugs Revenue in 2022
3.5 Global Key Players of Prostate Cancer Treatment Drugs Head office and Area Served
3.6 Global Key Players of Prostate Cancer Treatment Drugs, Product and Application
3.7 Global Key Players of Prostate Cancer Treatment Drugs, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Prostate Cancer Treatment Drugs Breakdown Data by Type
4.1 Global Prostate Cancer Treatment Drugs Historic Market Size by Type (2018-2023)
4.2 Global Prostate Cancer Treatment Drugs Forecasted Market Size by Type (2024-2029)
5 Prostate Cancer Treatment Drugs Breakdown Data by Application
5.1 Global Prostate Cancer Treatment Drugs Historic Market Size by Application (2018-2023)
5.2 Global Prostate Cancer Treatment Drugs Forecasted Market Size by Application (2024-2029)
6 North America
6.1 North America Prostate Cancer Treatment Drugs Market Size (2018-2029)
6.2 North America Prostate Cancer Treatment Drugs Market Size by Type
6.2.1 North America Prostate Cancer Treatment Drugs Market Size by Type (2018-2023)
6.2.2 North America Prostate Cancer Treatment Drugs Market Size by Type (2024-2029)
6.2.3 North America Prostate Cancer Treatment Drugs Market Share by Type (2018-2029)
6.3 North America Prostate Cancer Treatment Drugs Market Size by Application
6.3.1 North America Prostate Cancer Treatment Drugs Market Size by Application (2018-2023)
6.3.2 North America Prostate Cancer Treatment Drugs Market Size by Application (2024-2029)
6.3.3 North America Prostate Cancer Treatment Drugs Market Share by Application (2018-2029)
6.4 North America Prostate Cancer Treatment Drugs Market Size by Country
6.4.1 North America Prostate Cancer Treatment Drugs Market Size by Country: 2018 VS 2022 VS 2029
6.4.2 North America Prostate Cancer Treatment Drugs Market Size by Country (2018-2023)
6.4.3 North America Prostate Cancer Treatment Drugs Market Size by Country (2024-2029)
6.4.4 U.S.
6.4.5 Canada
7 Europe
7.1 Europe Prostate Cancer Treatment Drugs Market Size (2018-2029)
7.2 Europe Prostate Cancer Treatment Drugs Market Size by Type
7.2.1 Europe Prostate Cancer Treatment Drugs Market Size by Type (2018-2023)
7.2.2 Europe Prostate Cancer Treatment Drugs Market Size by Type (2024-2029)
7.2.3 Europe Prostate Cancer Treatment Drugs Market Share by Type (2018-2029)
7.3 Europe Prostate Cancer Treatment Drugs Market Size by Application
7.3.1 Europe Prostate Cancer Treatment Drugs Market Size by Application (2018-2023)
7.3.2 Europe Prostate Cancer Treatment Drugs Market Size by Application (2024-2029)
7.3.3 Europe Prostate Cancer Treatment Drugs Market Share by Application (2018-2029)
7.4 Europe Prostate Cancer Treatment Drugs Market Size by Country
7.4.1 Europe Prostate Cancer Treatment Drugs Market Size by Country: 2018 VS 2022 VS 2029
7.4.2 Europe Prostate Cancer Treatment Drugs Market Size by Country (2018-2023)
7.4.3 Europe Prostate Cancer Treatment Drugs Market Size by Country (2024-2029)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic Countries
8 China
8.1 China Prostate Cancer Treatment Drugs Market Size (2018-2029)
8.2 China Prostate Cancer Treatment Drugs Market Size by Type
8.2.1 China Prostate Cancer Treatment Drugs Market Size by Type (2018-2023)
8.2.2 China Prostate Cancer Treatment Drugs Market Size by Type (2024-2029)
8.2.3 China Prostate Cancer Treatment Drugs Market Share by Type (2018-2029)
8.3 China Prostate Cancer Treatment Drugs Market Size by Application
8.3.1 China Prostate Cancer Treatment Drugs Market Size by Application (2018-2023)
8.3.2 China Prostate Cancer Treatment Drugs Market Size by Application (2024-2029)
8.3.3 China Prostate Cancer Treatment Drugs Market Share by Application (2018-2029)
9 Asia (excluding China)
9.1 Asia Prostate Cancer Treatment Drugs Market Size (2018-2029)
9.2 Asia Prostate Cancer Treatment Drugs Market Size by Type
9.2.1 Asia Prostate Cancer Treatment Drugs Market Size by Type (2018-2023)
9.2.2 Asia Prostate Cancer Treatment Drugs Market Size by Type (2024-2029)
9.2.3 Asia Prostate Cancer Treatment Drugs Market Share by Type (2018-2029)
9.3 Asia Prostate Cancer Treatment Drugs Market Size by Application
9.3.1 Asia Prostate Cancer Treatment Drugs Market Size by Application (2018-2023)
9.3.2 Asia Prostate Cancer Treatment Drugs Market Size by Application (2024-2029)
9.3.3 Asia Prostate Cancer Treatment Drugs Market Share by Application (2018-2029)
9.4 Asia Prostate Cancer Treatment Drugs Market Size by Region
9.4.1 Asia Prostate Cancer Treatment Drugs Market Size by Region: 2018 VS 2022 VS 2029
9.4.2 Asia Prostate Cancer Treatment Drugs Market Size by Region (2018-2023)
9.4.3 Asia Prostate Cancer Treatment Drugs Market Size by Region (2024-2029)
9.4.4 Japan
9.4.5 South Korea
9.4.6 China Taiwan
9.4.7 Southeast Asia
9.4.8 India
9.4.9 Australia
10 Middle East, Africa, and Latin America
10.1 Middle East, Africa, and Latin America Prostate Cancer Treatment Drugs Market Size (2018-2029)
10.2 Middle East, Africa, and Latin America Prostate Cancer Treatment Drugs Market Size by Type
10.2.1 Middle East, Africa, and Latin America Prostate Cancer Treatment Drugs Market Size by Type (2018-2023)
10.2.2 Middle East, Africa, and Latin America Prostate Cancer Treatment Drugs Market Size by Type (2024-2029)
10.2.3 Middle East, Africa, and Latin America Prostate Cancer Treatment Drugs Market Share by Type (2018-2029)
10.3 Middle East, Africa, and Latin America Prostate Cancer Treatment Drugs Market Size by Application
10.3.1 Middle East, Africa, and Latin America Prostate Cancer Treatment Drugs Market Size by Application (2018-2023)
10.3.2 Middle East, Africa, and Latin America Prostate Cancer Treatment Drugs Market Size by Application (2024-2029)
10.3.3 Middle East, Africa, and Latin America Prostate Cancer Treatment Drugs Market Share by Application (2018-2029)
10.4 Middle East, Africa, and Latin America Prostate Cancer Treatment Drugs Market Size by Country
10.4.1 Middle East, Africa, and Latin America Prostate Cancer Treatment Drugs Market Size by Country: 2018 VS 2022 VS 2029
10.4.2 Middle East, Africa, and Latin America Prostate Cancer Treatment Drugs Market Size by Country (2018-2023)
10.4.3 Middle East, Africa, and Latin America Prostate Cancer Treatment Drugs Market Size by Country (2024-2029)
10.4.4 Brazil
10.4.5 Mexico
10.4.6 Turkey
10.4.7 Saudi Arabia
10.4.8 Israel
10.4.9 GCC Countries
11 Key Players Profiles
11.1 Johnson & Johnson
11.1.1 Johnson & Johnson Company Details
11.1.2 Johnson & Johnson Business Overview
11.1.3 Johnson & Johnson Prostate Cancer Treatment Drugs Introduction
11.1.4 Johnson & Johnson Revenue in Prostate Cancer Treatment Drugs Business (2018-2023)
11.1.5 Johnson & Johnson Recent Developments
11.2 Astella
11.2.1 Astella Company Details
11.2.2 Astella Business Overview
11.2.3 Astella Prostate Cancer Treatment Drugs Introduction
11.2.4 Astella Revenue in Prostate Cancer Treatment Drugs Business (2018-2023)
11.2.5 Astella Recent Developments
11.3 Sanofi
11.3.1 Sanofi Company Details
11.3.2 Sanofi Business Overview
11.3.3 Sanofi Prostate Cancer Treatment Drugs Introduction
11.3.4 Sanofi Revenue in Prostate Cancer Treatment Drugs Business (2018-2023)
11.3.5 Sanofi Recent Developments
11.4 Ipsen
11.4.1 Ipsen Company Details
11.4.2 Ipsen Business Overview
11.4.3 Ipsen Prostate Cancer Treatment Drugs Introduction
11.4.4 Ipsen Revenue in Prostate Cancer Treatment Drugs Business (2018-2023)
11.4.5 Ipsen Recent Developments
11.5 Bayer
11.5.1 Bayer Company Details
11.5.2 Bayer Business Overview
11.5.3 Bayer Prostate Cancer Treatment Drugs Introduction
11.5.4 Bayer Revenue in Prostate Cancer Treatment Drugs Business (2018-2023)
11.5.5 Bayer Recent Developments
11.6 AstraZeneca
11.6.1 AstraZeneca Company Details
11.6.2 AstraZeneca Business Overview
11.6.3 AstraZeneca Prostate Cancer Treatment Drugs Introduction
11.6.4 AstraZeneca Revenue in Prostate Cancer Treatment Drugs Business (2018-2023)
11.6.5 AstraZeneca Recent Developments
11.7 Dendreon
11.7.1 Dendreon Company Details
11.7.2 Dendreon Business Overview
11.7.3 Dendreon Prostate Cancer Treatment Drugs Introduction
11.7.4 Dendreon Revenue in Prostate Cancer Treatment Drugs Business (2018-2023)
11.7.5 Dendreon Recent Developments
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of Tables
Table 1. Global Prostate Cancer Treatment Drugs Market Size Growth Rate by Type (US$ Million), 2018 VS 2022 VS 2029
Table 2. Key Players of Zytiga
Table 3. Key Players of Gonax
Table 4. Key Players of Lupron
Table 5. Key Players of Zoladex
Table 6. Key Players of Decapeptyl
Table 7. Key Players of Eligard
Table 8. Key Players of Vantas
Table 9. Key Players of Casodex
Table 10. Key Players of Others
Table 11. Global Prostate Cancer Treatment Drugs Market Size Growth Rate by Application (US$ Million), 2018 VS 2022 VS 2029
Table 12. Global Prostate Cancer Treatment Drugs Market Size Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2029
Table 13. Global Prostate Cancer Treatment Drugs Market Size by Region (2018-2023) & (US$ Million)
Table 14. Global Prostate Cancer Treatment Drugs Market Share by Region (2018-2023)
Table 15. Global Prostate Cancer Treatment Drugs Forecasted Market Size by Region (2024-2029) & (US$ Million)
Table 16. Global Prostate Cancer Treatment Drugs Market Share by Region (2024-2029)
Table 17. Prostate Cancer Treatment Drugs Market Trends
Table 18. Prostate Cancer Treatment Drugs Market Drivers
Table 19. Prostate Cancer Treatment Drugs Market Challenges
Table 20. Prostate Cancer Treatment Drugs Market Restraints
Table 21. Global Prostate Cancer Treatment Drugs Revenue by Players (2018-2023) & (US$ Million)
Table 22. Global Prostate Cancer Treatment Drugs Revenue Share by Players (2018-2023)
Table 23. Global Top Prostate Cancer Treatment Drugs by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Prostate Cancer Treatment Drugs as of 2022)
Table 24. Global Prostate Cancer Treatment Drugs Industry Ranking 2021 VS 2022 VS 2023
Table 25. Global 5 Largest Players Market Share by Prostate Cancer Treatment Drugs Revenue (CR5 and HHI) & (2018-2023)
Table 26. Global Key Players of Prostate Cancer Treatment Drugs, Headquarters and Area Served
Table 27. Global Key Players of Prostate Cancer Treatment Drugs, Product and Application
Table 28. Global Key Players of Prostate Cancer Treatment Drugs, Product and Application
Table 29. Mergers & Acquisitions, Expansion Plans
Table 30. Global Prostate Cancer Treatment Drugs Market Size by Type (2018-2023) & (US$ Million)
Table 31. Global Prostate Cancer Treatment Drugs Revenue Market Share by Type (2018-2023)
Table 32. Global Prostate Cancer Treatment Drugs Forecasted Market Size by Type (2024-2029) & (US$ Million)
Table 33. Global Prostate Cancer Treatment Drugs Revenue Market Share by Type (2024-2029)
Table 34. Global Prostate Cancer Treatment Drugs Market Size by Application (2018-2023) & (US$ Million)
Table 35. Global Prostate Cancer Treatment Drugs Revenue Share by Application (2018-2023)
Table 36. Global Prostate Cancer Treatment Drugs Forecasted Market Size by Application (2024-2029) & (US$ Million)
Table 37. Global Prostate Cancer Treatment Drugs Revenue Share by Application (2024-2029)
Table 38. North America Prostate Cancer Treatment Drugs Market Size by Type (2018-2023) & (US$ Million)
Table 39. North America Prostate Cancer Treatment Drugs Market Size by Type (2024-2029) & (US$ Million)
Table 40. North America Prostate Cancer Treatment Drugs Market Size by Application (2018-2023) & (US$ Million)
Table 41. North America Prostate Cancer Treatment Drugs Market Size by Application (2024-2029) & (US$ Million)
Table 42. North America Prostate Cancer Treatment Drugs Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2029
Table 43. North America Prostate Cancer Treatment Drugs Market Size by Country (2018-2023) & (US$ Million)
Table 44. North America Prostate Cancer Treatment Drugs Market Size by Country (2024-2029) & (US$ Million)
Table 45. Europe Prostate Cancer Treatment Drugs Market Size by Type (2018-2023) & (US$ Million)
Table 46. Europe Prostate Cancer Treatment Drugs Market Size by Type (2024-2029) & (US$ Million)
Table 47. Europe Prostate Cancer Treatment Drugs Market Size by Application (2018-2023) & (US$ Million)
Table 48. Europe Prostate Cancer Treatment Drugs Market Size by Application (2024-2029) & (US$ Million)
Table 49. Europe Prostate Cancer Treatment Drugs Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2029
Table 50. Europe Prostate Cancer Treatment Drugs Market Size by Country (2018-2023) & (US$ Million)
Table 51. Europe Prostate Cancer Treatment Drugs Market Size by Country (2024-2029) & (US$ Million)
Table 52. China Prostate Cancer Treatment Drugs Market Size by Type (2018-2023) & (US$ Million)
Table 53. China Prostate Cancer Treatment Drugs Market Size by Type (2024-2029) & (US$ Million)
Table 54. China Prostate Cancer Treatment Drugs Market Size by Application (2018-2023) & (US$ Million)
Table 55. China Prostate Cancer Treatment Drugs Market Size by Application (2024-2029) & (US$ Million)
Table 56. Asia Prostate Cancer Treatment Drugs Market Size by Type (2018-2023) & (US$ Million)
Table 57. Asia Prostate Cancer Treatment Drugs Market Size by Type (2024-2029) & (US$ Million)
Table 58. Asia Prostate Cancer Treatment Drugs Market Size by Application (2018-2023) & (US$ Million)
Table 59. Asia Prostate Cancer Treatment Drugs Market Size by Application (2024-2029) & (US$ Million)
Table 60. Asia Prostate Cancer Treatment Drugs Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2029
Table 61. Asia Prostate Cancer Treatment Drugs Market Size by Region (2018-2023) & (US$ Million)
Table 62. Asia Prostate Cancer Treatment Drugs Market Size by Region (2024-2029) & (US$ Million)
Table 63. Middle East, Africa, and Latin America Prostate Cancer Treatment Drugs Market Size by Type (2018-2023) & (US$ Million)
Table 64. Middle East, Africa, and Latin America Prostate Cancer Treatment Drugs Market Size by Type (2024-2029) & (US$ Million)
Table 65. Middle East, Africa, and Latin America Prostate Cancer Treatment Drugs Market Size by Application (2018-2023) & (US$ Million)
Table 66. Middle East, Africa, and Latin America Prostate Cancer Treatment Drugs Market Size by Application (2024-2029) & (US$ Million)
Table 67. Middle East, Africa, and Latin America Prostate Cancer Treatment Drugs Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2029
Table 68. Middle East, Africa, and Latin America Prostate Cancer Treatment Drugs Market Size by Country (2018-2023) & (US$ Million)
Table 69. Middle East, Africa, and Latin America Prostate Cancer Treatment Drugs Market Size by Country (2024-2029) & (US$ Million)
Table 70. Johnson & Johnson Company Details
Table 71. Johnson & Johnson Business Overview
Table 72. Johnson & Johnson Prostate Cancer Treatment Drugs Product
Table 73. Johnson & Johnson Revenue in Prostate Cancer Treatment Drugs Business (2018-2023) & (US$ Million)
Table 74. Johnson & Johnson Recent Developments
Table 75. Astella Company Details
Table 76. Astella Business Overview
Table 77. Astella Prostate Cancer Treatment Drugs Product
Table 78. Astella Revenue in Prostate Cancer Treatment Drugs Business (2018-2023) & (US$ Million)
Table 79. Astella Recent Developments
Table 80. Sanofi Company Details
Table 81. Sanofi Business Overview
Table 82. Sanofi Prostate Cancer Treatment Drugs Product
Table 83. Sanofi Revenue in Prostate Cancer Treatment Drugs Business (2018-2023) & (US$ Million)
Table 84. Sanofi Recent Developments
Table 85. Ipsen Company Details
Table 86. Ipsen Business Overview
Table 87. Ipsen Prostate Cancer Treatment Drugs Product
Table 88. Ipsen Revenue in Prostate Cancer Treatment Drugs Business (2018-2023) & (US$ Million)
Table 89. Ipsen Recent Developments
Table 90. Bayer Company Details
Table 91. Bayer Business Overview
Table 92. Bayer Prostate Cancer Treatment Drugs Product
Table 93. Bayer Revenue in Prostate Cancer Treatment Drugs Business (2018-2023) & (US$ Million)
Table 94. Bayer Recent Developments
Table 95. AstraZeneca Company Details
Table 96. AstraZeneca Business Overview
Table 97. AstraZeneca Prostate Cancer Treatment Drugs Product
Table 98. AstraZeneca Revenue in Prostate Cancer Treatment Drugs Business (2018-2023) & (US$ Million)
Table 99. AstraZeneca Recent Developments
Table 100. Dendreon Company Details
Table 101. Dendreon Business Overview
Table 102. Dendreon Prostate Cancer Treatment Drugs Product
Table 103. Dendreon Revenue in Prostate Cancer Treatment Drugs Business (2018-2023) & (US$ Million)
Table 104. Dendreon Recent Developments
Table 105. Research Programs/Design for This Report
Table 106. Key Data Information from Secondary Sources
Table 107. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Prostate Cancer Treatment Drugs Market Size Growth Rate by Type, 2018 VS 2022 VS 2029 (US$ Million)
Figure 2. Global Prostate Cancer Treatment Drugs Market Share by Type: 2022 VS 2029
Figure 3. Zytiga Features
Figure 4. Gonax Features
Figure 5. Lupron Features
Figure 6. Zoladex Features
Figure 7. Decapeptyl Features
Figure 8. Eligard Features
Figure 9. Vantas Features
Figure 10. Casodex Features
Figure 11. Others Features
Figure 12. Global Prostate Cancer Treatment Drugs Market Size Growth Rate by Application, 2018 VS 2022 VS 2029 (US$ Million)
Figure 13. Global Prostate Cancer Treatment Drugs Market Share by Application: 2022 VS 2029
Figure 14. Hospitals Case Studies
Figure 15. Ambulatory Surgical Centers Case Studies
Figure 16. Clinics Case Studies
Figure 17. Prostate Cancer Treatment Drugs Report Years Considered
Figure 18. Global Prostate Cancer Treatment Drugs Market Size (US$ Million), Year-over-Year: 2018-2029
Figure 19. Global Prostate Cancer Treatment Drugs Market Size, (US$ Million), 2018 VS 2022 VS 2029
Figure 20. Global Prostate Cancer Treatment Drugs Market Share by Region: 2022 VS 2029
Figure 21. Global Prostate Cancer Treatment Drugs Market Share by Players in 2022
Figure 22. Global Top Prostate Cancer Treatment Drugs Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Prostate Cancer Treatment Drugs as of 2022)
Figure 23. The Top 10 and 5 Players Market Share by Prostate Cancer Treatment Drugs Revenue in 2022
Figure 24. North America Prostate Cancer Treatment Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 25. North America Prostate Cancer Treatment Drugs Market Share by Type (2018-2029)
Figure 26. North America Prostate Cancer Treatment Drugs Market Share by Application (2018-2029)
Figure 27. North America Prostate Cancer Treatment Drugs Market Share by Country (2018-2029)
Figure 28. United States Prostate Cancer Treatment Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 29. Canada Prostate Cancer Treatment Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 30. Europe Prostate Cancer Treatment Drugs Market Size YoY (2018-2029) & (US$ Million)
Figure 31. Europe Prostate Cancer Treatment Drugs Market Share by Type (2018-2029)
Figure 32. Europe Prostate Cancer Treatment Drugs Market Share by Application (2018-2029)
Figure 33. Europe Prostate Cancer Treatment Drugs Market Share by Country (2018-2029)
Figure 34. Germany Prostate Cancer Treatment Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 35. France Prostate Cancer Treatment Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 36. U.K. Prostate Cancer Treatment Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 37. Italy Prostate Cancer Treatment Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 38. Russia Prostate Cancer Treatment Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 39. Nordic Countries Prostate Cancer Treatment Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 40. China Prostate Cancer Treatment Drugs Market Size YoY (2018-2029) & (US$ Million)
Figure 41. China Prostate Cancer Treatment Drugs Market Share by Type (2018-2029)
Figure 42. China Prostate Cancer Treatment Drugs Market Share by Application (2018-2029)
Figure 43. Asia Prostate Cancer Treatment Drugs Market Size YoY (2018-2029) & (US$ Million)
Figure 44. Asia Prostate Cancer Treatment Drugs Market Share by Type (2018-2029)
Figure 45. Asia Prostate Cancer Treatment Drugs Market Share by Application (2018-2029)
Figure 46. Asia Prostate Cancer Treatment Drugs Market Share by Region (2018-2029)
Figure 47. Japan Prostate Cancer Treatment Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 48. South Korea Prostate Cancer Treatment Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 49. China Taiwan Prostate Cancer Treatment Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 50. Southeast Asia Prostate Cancer Treatment Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 51. India Prostate Cancer Treatment Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 52. Australia Prostate Cancer Treatment Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 53. Middle East, Africa, and Latin America Prostate Cancer Treatment Drugs Market Size YoY (2018-2029) & (US$ Million)
Figure 54. Middle East, Africa, and Latin America Prostate Cancer Treatment Drugs Market Share by Type (2018-2029)
Figure 55. Middle East, Africa, and Latin America Prostate Cancer Treatment Drugs Market Share by Application (2018-2029)
Figure 56. Middle East, Africa, and Latin America Prostate Cancer Treatment Drugs Market Share by Country (2018-2029)
Figure 57. Brazil Prostate Cancer Treatment Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 58. Mexico Prostate Cancer Treatment Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 59. Turkey Prostate Cancer Treatment Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 60. Saudi Arabia Prostate Cancer Treatment Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 61. Israel Prostate Cancer Treatment Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 62. GCC Countries Prostate Cancer Treatment Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 63. Johnson & Johnson Revenue Growth Rate in Prostate Cancer Treatment Drugs Business (2018-2023)
Figure 64. Astella Revenue Growth Rate in Prostate Cancer Treatment Drugs Business (2018-2023)
Figure 65. Sanofi Revenue Growth Rate in Prostate Cancer Treatment Drugs Business (2018-2023)
Figure 66. Ipsen Revenue Growth Rate in Prostate Cancer Treatment Drugs Business (2018-2023)
Figure 67. Bayer Revenue Growth Rate in Prostate Cancer Treatment Drugs Business (2018-2023)
Figure 68. AstraZeneca Revenue Growth Rate in Prostate Cancer Treatment Drugs Business (2018-2023)
Figure 69. Dendreon Revenue Growth Rate in Prostate Cancer Treatment Drugs Business (2018-2023)
Figure 70. Bottom-up and Top-down Approaches for This Report
Figure 71. Data Triangulation
Figure 72. Key Executives Interviewed
|
Prostate Cancer Treatment Drugs Markets in China
China's demand for Prostate Cancer Treatment Drugs has grown at a fast pace in the past decade. In the next decade, both production and demand will continue to grow. The Chinese economy maintains a high speed growth which has been stimulated by the c... |
|
Prostate Cancer Treatment Drugs Companies in China
This study focuses on Chinas Prostate Cancer Treatment Drugs industry assessments and company profiles. In the two past decades, the industry has been growing at a fast pace. The dramatic expansions of the manufacturing capabilities and rising consu... |
|
Prostate Cancer Treatment Drugs Industry Forecasts - China Focus
This study focuses on Chinas Prostate Cancer Treatment Drugs industry forecasts. In the two past decades, the industry has been growing at a fast pace. The dramatic expansions of the manufacturing capabilities and rising consumer consumptions in Chi... |
|
Global Prostate Cancer Treatment Drugs Market Research Report 2023
Adoption of innovative technologies in screening & diagnostic tests is projected to drive growth. The incorporation of multiparametric MRI (mp-MRI) can significantly improve the detection of tumor and also provide confirmation whether there is a need... |
|
Global Prostate Cancer Treatment Drugs Professional Survey Report 2023, Forecast to 2028
Docetaxel (Taxotere) Cabazitaxel (Jevtana) Mitoxantrone (Novantrone) Estramustine (Emcyt) Our market research experts provide qualitative and quantitative analysis of the market based on involving economic and non-economic factors in the same ... |
|
Global Prostate Cancer Treatment Drugs Market Research Report 2023, Forecast to 2028
Docetaxel (Taxotere) Cabazitaxel (Jevtana) Mitoxantrone (Novantrone) Estramustine (Emcyt) Our market research experts provide qualitative and quantitative analysis of the market based on involving economic and non-economic factors in the same ... |
|
Global Prostate Cancer Treatment Drugs Market Insights, Forecast to 2028
Prostate Cancer Treatment Drugs market is segmented by players, region (country), by Type and by Application. Players, stakeholders, and other participants in the global Prostate Cancer Treatment Drugs market will be able to gain the upper hand as th... |
|
Global Prostate Cancer Treatment Drugs Market Growth (Status and Outlook) 2022-2028
As the global economy mends, the 2021 growth of Prostate Cancer Treatment Drugs will have significant change from previous year. According to our (LP Information) latest study, the global Prostate Cancer Treatment Drugs market size is USD million in ... |
|
Global and United States Prostate Cancer Treatment Drugs Market Report & Forecast 2022-2028
Prostate Cancer Treatment Drugs market is segmented by region (country), players, by Type and by Application. Players, stakeholders, and other participants in the global Prostate Cancer Treatment Drugs market will be able to gain the upper hand as th... |
|
Global Prostate Cancer Treatment Drugs Market 2022 by Company, Regions, Type and Application, Forecast to 2028
The Prostate Cancer Treatment Drugs market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and glob... |
